MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer

Ji Heon Noh1, Young Gyoon Chang, Min Gyu Kim

  • 1Lab of Oncogenomics, Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Cancer Letters
|March 19, 2013
PubMed

Insights

Loss of miR-145 in hepatocellular carcinoma (HCC) leads to increased histone deacetylase 2 (HDAC2) expression. Restoring miR-145 suppresses tumor growth, suggesting a novel therapeutic target for HCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Aberrant histone deacetylase 2 (HDAC2) regulation is implicated in hepatocellular carcinoma (HCC) development.
  • The specific mechanisms driving HDAC2 overexpression in HCC remain unclear.

Purpose of the Study:

  • To investigate the role of microRNAs (miRNAs) in regulating HDAC2 expression in HCC.
  • To identify specific miRNAs that target HDAC2 and their functional impact on HCC progression.

Main Methods:

  • miRNA profiling was conducted on a subset of HCC samples.
  • Ectopic expression of miRNA mimics was used to assess the effect on HDAC2 levels in HCC cells.
  • Functional assays were performed to evaluate the impact on cancer cell growth.

Main Results:

  • Four downregulated miRNAs potentially targeting HDAC2 were identified in HCC.
  • miR-145 was confirmed to suppress HDAC2 expression in HCC cells.
  • Restoration of miR-145 inhibited HCC cell proliferation and mimicked the effects of HDAC2 knockdown.

Conclusions:

  • Loss or suppression of miR-145 contributes to aberrant HDAC2 overexpression in HCC.
  • miR-145 acts as a tumor suppressor by inhibiting HDAC2, presenting a potential therapeutic strategy for HCC.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...